Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
07 Février 2024 - 1:00PM
Business Wire
Nanophoton Strengthens Bruker’s Portfolio of
Molecular Microscopy Research Solutions
Bruker Corporation (Nasdaq: BRKR) today announced the
acquisition of Nanophoton Corporation, a pioneer focused on
advanced research Raman microscopy systems. Headquartered in Osaka,
Nanophoton offers a broad portfolio of advanced Raman microscopes,
serving academic and industrial research customers, primarily in
Japan. This acquisition fills a gap in Bruker’s molecular
microscopy portfolio, and Bruker is looking forward to offering
fast, flexible and sensitive Nanophoton Raman microscopy systems
worldwide for research and development in the life sciences,
biopharma, advanced materials, semiconductors and polymers.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240207642491/en/
The Nanophoton RAMANtouch™ high-speed
Raman microscope allows the simultaneous measurement of 400
high-quality Raman spectra for high-resolution spectral imaging
(Photo: Business Wire)
Nanophoton augments the molecular microscopy portfolio of the
Bruker Optics division with a broad range of state-of-the-art Raman
microscopy systems, which offer exceptional speed, sensitivity and
spatial resolution, combined with user-friendly workflows designed
for outstanding user experience. The applications include
inspecting advanced semiconductor and nanomaterials, batteries,
organic and liquid-crystal displays, nanocarbon materials,
identifying organic components, mapping the distribution of active
pharmaceutical ingredients and excipients in tablets, and clinical
research on disease patterns in tissues.
Professor Satoshi Kawata, the CEO founder of Nanophoton,
commented: “We recently celebrated our 20th anniversary of
Nanophoton and are delighted to open a new chapter in our history
together with Bruker. Bruker is the ideal partner for Nanophoton to
accelerate our growth, bring our unique Raman systems to customers
worldwide and to develop unparalleled Raman imaging technologies
together.”
Dr. Andreas Kamlowski, the President of the Bruker Optics
division, added: “We warmly welcome the Nanophoton team to Bruker,
and acknowledge their outstanding track record and expertise in
innovating in Raman microscopy. We are look forward to this new
opportunity to bring the differentiated Nanophoton Raman imaging
systems to our research customers worldwide with global
support.”
Financial terms of the transaction were not disclosed. In 2023,
Nanophoton Corporation had revenues of approximately $5 million,
and was near break-even.
About Nanophoton
Nanophoton was founded in 2003 as the world's only dedicated
Raman microscope manufacturer. Nanophoton has developed,
manufactured, and sold unique laser-scanning Raman microscopes,
including a line-illumination confocal Raman microscope that
reduces measurement time by several hundred times and a Raman
microscope that employs a unique beam-scanning method based on
stochastic process and information theories. Other products
Nanophoton has commercialized include the Raman microscopes for
deep ultraviolet, for 30-cm wafers, and for long depth of focus
imaging. The company also markets unique optical components such as
speckle reducers and radial/azimuthal polarizers. Nanophoton has
received overwhelming support from many customers, especially in
Japan and Korea. For more information, please visit:
www.nanophoton.jp, or www.nanophoton.net.
About Bruker Corporation
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular and cell biology research, in applied and pharma
applications, in microscopy and nanoanalysis, as well as in
industrial applications. Bruker offers differentiated, high-value
life science and diagnostics systems and solutions in preclinical
imaging, clinical phenomics research, proteomics and multiomics,
spatial and single-cell biology, functional structural and
condensate biology, as well as in clinical microbiology and
molecular diagnostics. For more information, please visit:
www.bruker.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240207642491/en/
Investors: Justin Ward Sr. Director, Investor Relations
& Corporate Development Bruker Corporation T: +1 (978) 313-5800
E: Investor.Relations@bruker.com Media: Michael Mueller
Marketing Manager Bruker Optics GmbH & Co. KG T: +49 7243 504
2652
Bruker (NASDAQ:BRKR)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Bruker (NASDAQ:BRKR)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024